Agranulocytosis due to and following cancer chemotherapy

disorder

SNOMED 350691000119103CUI C5547205

Overview

Agranulocytosis due to and following cancer chemotherapy is a disorder.

Auto-generated from clinical reference data. Not a substitute for medical advice.

Related Conditions

Complication of introduction procedure(parent)

Complication of chemotherapy(parent)

Agranulocytosis(parent)

Disorder following clinical procedure(parent)

Quick Facts

SNOMED CT: 350691000119103
UMLS CUI: C5547205
Fully Specified Name: Agranulocytosis due to and following administration of antineoplastic agent (disorder)
Specialists: 0
Diagnostic Biomarkers: 0

Medical Disclaimer

This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider regarding any medical condition or treatment plan.

Clinical content is derived from the SNOMED CT clinical ontology and curated medical knowledge graphs.

Agranulocytosis due to and following cancer chemotherapy — Symptoms, Testing & Specialists | Ltrl